EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neuroprotective Potential of Glycyrrhizic Acid in Ischemic Stroke: Mechanisms and Therapeutic Prospects

Yanwen Li iD, Juan Wu, Fang Du, Tao Tang, Jonathan Chee Woei Lim, Thilakavathy Karuppiah iD, Jiaxin Liu iD, Zhong Sun iD

Pharmaceuticals · 07.11.2024 · 17 (11) · 1493

DOI: 10.3390/ph17111493 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 07.11.2024. Verfasst von Yanwen Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medicine, Medical School, Kunming University of Science and Technology, Kunming 650500, China. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Special Project of Yunnan Provincial Department of Science and Technology, Kunming University of Science and Technology for Applied Basic Research, Kunming University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Ischemic stroke is a leading cause of disability and mortality worldwide, with current therapies limited in addressing its complex pathophysiological mechanisms, such as inflammation, oxidative stress, apoptosis, and impaired autophagy. Glycyrrhizic acid (GA), a bioactive compound from licorice (Glycyrrhiza glabra L.), has demonstrated neuroprotective properties in preclinical studies. This review consolidates current evidence on GA’s pharmacological mechanisms and assesses its potential as a therapeutic agent for ischemic stroke.

Methods

This review examines findings from recent preclinical studies and reviews on GA’s neuroprotective effects, focusing on its modulation of inflammation, oxidative stress, apoptosis, and autophagy. Studies were identified from major scientific databases, including PubMed, Web of Science, and Embase, covering research from January 2000 to August 2024.

Results

GA has demonstrated significant neuroprotective effects through the modulation of key pathways, including HMGB1/TLR4/NF-κB and Keap1/Nrf2, thereby reducing neuroinflammation, oxidative stress, and apoptosis. Additionally, GA promotes autophagy and modulates immune responses, suggesting it could serve as an adjunct therapy to enhance the efficacy and safety of existing treatments, such as thrombolysis.

Conclusions

Current findings underscore GA’s potential as a multi-targeted neuroprotective agent in ischemic stroke, highlighting its anti-inflammatory, antioxidant, and anti-apoptotic properties. However, while preclinical data are promising, further clinical trials are necessary to validate GA’s therapeutic potential in humans. This review provides a comprehensive overview of GA’s mechanisms of action, proposing directions for future research to explore its role in ischemic stroke management.

Schlagwörter

Stichwörter der Autor:innen

Glycyrrhiza glabraHMGB1Keap1/Nrf2apoptosisautophagycerebral ischemia-reperfusion injuryglycyrrhizic acidischemic strokeneuroprotectionoxidative stress

Autor:innen und Institutionen

  • Department of Basic Medicine, Medical School, Kunming University of Science and Technology, Kunming 650500, China.
  • Department of Medicine, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia, UPM, Serdang 43400, Malaysia.
  • Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia, UPM, Serdang 43400, Malaysia.
  • Genetics and Regenerative Medicine Research Centre, Universiti Putra Malaysia, UPM, Serdang 43400, Malaysia.

ORCID-Profile: Yanwen Li, Thilakavathy Karuppiah, Jiaxin Liu, Zhong Sun

Förderung

  • Joint Special Project of Yunnan Provincial Department of Science and Technology, Kunming University of Science and Technology for Applied Basic Research
  • Kunming University of Science and Technology

Zitieren

APA

Li, Y., Wu, J., Du, F., Tang, T., Lim, J. C. W., Karuppiah, T., Liu, J., & Sun, Z. (2024). Neuroprotective Potential of Glycyrrhizic Acid in Ischemic Stroke: Mechanisms and Therapeutic Prospects. Pharmaceuticals, 17(11), 1493. https://doi.org/10.3390/ph17111493

Vancouver

Li Y, Wu J, Du F, Tang T, Lim JCW, Karuppiah T, et al. Neuroprotective Potential of Glycyrrhizic Acid in Ischemic Stroke: Mechanisms and Therapeutic Prospects. Pharmaceuticals. 2024;17(11):1493. doi:10.3390/ph17111493

BibTeX
@article{Li2024,
  author = {Li, Yanwen and Wu, Juan and Du, Fang and Tang, Tao and Lim, Jonathan Chee Woei and Karuppiah, Thilakavathy and Liu, Jiaxin and Sun, Zhong},
  title = {Neuroprotective Potential of Glycyrrhizic Acid in Ischemic Stroke: Mechanisms and Therapeutic Prospects},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {11},
  pages = {1493},
  doi = {10.3390/ph17111493}
}
Kostenlos starten →